Latest News in the pharma Industry

Research & Development

BMS Demonstrates Commitment to Hematology and Advancing R&D Across Multiple Blood Cancers Through Immuno-Oncology Leadership

BMS Demonstrates Commitment to Hematology and Advancing R&D Across Multiple Blood Cancers Through Immuno-Oncology Leadership

11 Jun 2015

Read more 
LDC to Collaborate with Johnson & Johnson Innovation on Acceleration of Academic Drug Discovery Initiatives

LDC to Collaborate with Johnson & Johnson Innovation on Acceleration of Academic Drug Discovery Initiatives

11 Jun 2015

Read more 
TECOS, Merck’s Cardiovascular Safety Trial of Januvia (Sitagliptin), Met Primary Endpoint in Patients with Type 2 Diabetes

TECOS, Merck’s Cardiovascular Safety Trial of Januvia (Sitagliptin), Met Primary Endpoint in Patients with Type 2 Diabetes

9 Jun 2015

Read more 
Lilly's Basal Insulin Peglispro Shows Superiority to Insulin Glargine in Reducing HbA1c in People with Type 2 Diabetes

Lilly's Basal Insulin Peglispro Shows Superiority to Insulin Glargine in Reducing HbA1c in People with Type 2 Diabetes

8 Jun 2015

Read more 
Celgene and bluebird bio to Develop Anti-BCMA Product Candidates

Celgene and bluebird bio to Develop Anti-BCMA Product Candidates

5 Jun 2015

Read more 
Novartis Presents New Data at EULAR and WCD Further Demonstrating its Leadership in Severe Long-Term Inflammatory and Skin Conditions

Novartis Presents New Data at EULAR and WCD Further Demonstrating its Leadership in Severe Long-Term Inflammatory and Skin Conditions

5 Jun 2015

Read more 
Adding Investigational Agent Elotuzumab to Standard Treatment for Multiple Myeloma Significantly Reduced the Risk of Disease Progression

Adding Investigational Agent Elotuzumab to Standard Treatment for Multiple Myeloma Significantly Reduced the Risk of Disease Progression

3 Jun 2015

Read more 
Process uses 3-D Printing to Produce Tough but Flexible Hydrogel Structures

Process uses 3-D Printing to Produce Tough but Flexible Hydrogel Structures

2 Jun 2015

Read more 
Combination of Novartis Drugs Tafinlar and Mekinist Sshows Significant Survival Benefit in Patients with Metastatic Melanoma

Combination of Novartis Drugs Tafinlar and Mekinist Sshows Significant Survival Benefit in Patients with Metastatic Melanoma

1 Jun 2015

Read more 
Genentech’s Perjeta Regimen Helped People with HER2-Positive Early Breast Cancer Live Longer without Their Disease Returning or Getting Worse

Genentech’s Perjeta Regimen Helped People with HER2-Positive Early Breast Cancer Live Longer without Their Disease Returning or Getting Worse

1 Jun 2015

Read more 
Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumours

Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumours

29 May 2015

Read more 
Merck and NanoString Collaborate to Develop an Immune-Related Gene Expression Assay for Use in the Development Programme for Keytruda

Merck and NanoString Collaborate to Develop an Immune-Related Gene Expression Assay for Use in the Development Programme for Keytruda

28 May 2015

Read more